Episode 40: Theranostics: The Leading Edge of Precision Care in Cancer Treatment

This podcast was created with support from GE HealthCare Canada.

Theranostics is a patient-centric approach in medicine that combines diagnostic and therapeutic technologies to precisely visualize and treat cancer without harming healthy tissue. This innovative treatment method is an incredible showcase of technology in the health care system.

Featuring Mike Hamilton, CEO of GE HealthCare Canada, and Dr. Narinder Paul, Chief of Medical Imaging at St. Joseph’s Health Care London, this podcast explores the key aspects of theranostics, how it functions, the challenges of implementation in Canada, current applications, and a successful example of theranostics adoption in Ontario.

In this episode, we will learn about the real-world impact of theranostics and its potential to revolutionize patient care across Canada.

--

Mike Hamilton, Chief Executive Officer, GE HealthCare Canada

Mike Hamilton is a senior executive and board member with over 30 years’ experience in health care and medical technology, gained through progressively senior commercial and executive roles in Canada and internationally. Since September 2022, he has served as the President and CEO of GE HealthCare Canada, where he is responsible for shaping the vision for the Canadian division and implementing the commercial strategy across the entire range of Imaging, Ultrasound, Patient Care Solutions, and Digital Solutions. Additionally, Mike is involved with the C.D. Howe Institute’s Health Policy Council and serves on the Corporate Advisory Council of the Canadian College of Health Leaders. He earned his undergraduate degree in Biochemistry from Western University and holds an MBA from the Richard Ivey School of Business.

Dr. Narinder Paul, Chief of Medical Imaging at St. Joseph’s Health Care London

Dr. Paul obtained his medical degree in 1987 and has held significant academic and administrative roles at the University Health Network and the University of Toronto, eventually becoming a full Professor in 2015. He currently serves as Site Chief and Director at Toronto General Hospital, with his research primarily focused on radiation dose reduction and image optimization in cardiothoracic imaging, driven by patient needs and clinical translation. Dr. Paul also holds graduate appointments and has actively participated in numerous provincial, national, and international professional organizations, receiving multiple awards for his contributions to radiology.